Tempus AI Gross Margin 2023-2024 | TEM
Current and historical gross margin for Tempus AI (TEM) over the last 10 years. The current gross profit margin for Tempus AI as of December 31, 2024 is %.
| Tempus AI Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2024-12-31 | $0.69B | $0.38B | 55.04% |
| 2024-09-30 | $0.64B | $0.34B | 53.35% |
| 2024-06-30 | $0.60B | $0.31B | 52.01% |
| 2024-03-31 | $0.56B | $0.31B | 54.45% |
| 2023-12-31 | $0.53B | $0.29B | 53.95% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $8.988B | $0.693B |
| Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $37.877B | 52.32 |
| Hims & Hers Health (HIMS) | United States | $10.991B | 115.05 |
| Inspire Medical Systems (INSP) | United States | $4.774B | 74.60 |
| IRhythm Technologies (IRTC) | United States | $4.316B | 0.00 |
| Privia Health (PRVA) | United States | $2.756B | 206.54 |
| Enovis (ENOV) | United States | $1.947B | 12.05 |
| Schrodinger (SDGR) | United States | $1.721B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.712B | 0.00 |
| Phreesia (PHR) | United States | $1.426B | 0.00 |
| Omnicell (OMCL) | United States | $1.202B | 21.21 |
| Azenta (AZTA) | United States | $1.162B | 54.08 |
| 10x Genomics (TXG) | United States | $0.991B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.573B | 0.00 |
| Talkspace (TALK) | United States | $0.530B | 157.25 |
| Butterfly Network (BFLY) | United States | $0.527B | 0.00 |
| Veradigm (MDRX) | United States | $0.486B | 0.00 |
| Standard BioTools (LAB) | United States | $0.403B | 0.00 |
| TruBridge (TBRG) | United States | $0.381B | 0.00 |
| Claritev (CTEV) | United States | $0.329B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.286B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.218B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.200B | 0.00 |
| Pulmonx (LUNG) | United States | $0.138B | 0.00 |
| American Well (AMWL) | United States | $0.106B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.095B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.092B | 0.00 |
| CareCloud (CCLD) | United States | $0.091B | 3.45 |
| MDxHealth SA (MDXH) | Belgium | $0.080B | 0.00 |
| 111 (YI) | China | $0.069B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.063B | 0.00 |
| HeartBeam (BEAT) | United States | $0.062B | 0.00 |
| Outset Medical (OM) | United States | $0.041B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.040B | 0.00 |
| Zhongchao (ZCMD) | China | $0.033B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.016B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |